What is CMND's current stock price?

CMND (Clearmind Medicine Inc.) is currently trading at $2.26 with a market cap of $2.3M.

What sector is Clearmind Medicine Inc. in?

Clearmind Medicine Inc. (CMND) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

CMND Clearmind Medicine Inc.

Healthcare

$2.26-8.13%ClosedMarket Cap: $2.3M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.32

P/S

0.00

EV/EBITDA

0.94

DCF Value

$1.03

FCF Yield

-299.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-211.9%

ROA

-69.2%

ROIC

-114.6%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-3.9M	$—
Q4 null	$0.00	$-964.0K	$—
FY null	$0.00	$-3.9M	$—
Q3 null	$0.00	$-1.8M	$—

Trading Activity

Insider Trades

View All

Lamadrid Daviddirector, 10 percent owner, officer: CEO and President

SellTue May 16

Lamadrid Daviddirector, 10 percent owner, officer: CEO and President

SellFri May 05

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

-1.12

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Peers

GRI